• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • Our Team
  • What We Offer
    • Primary Care
    • Commercial
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • Medicine Management
        • EMIS: Antibiotics Prescribing & Optimisation
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • EMIS: GLP-1 NHS Obesity Programme (Tirzepatide)
      • Specialties
        • EMIS: Cardiovascular Disease Prevention & Management
        • EMIS: Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
        • EMIS: Cancer
        • EMIS Diabetes Overview
          • EMIS Diabetes
          • EMIS: Diabetes Technology
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS: NHS Health Checks
        • EMIS: Paediatric Assessment
        • EMIS: Palliative Care and End of Life
        • Chronic Kidney Disease (CKD) – EMIS
        • EMIS Renal Overview
        • Respiratory Overview
          • EMIS Respiratory Resources
          • BeatAsthma+ Guide for EMIS
        • EMIS: Rheumatology
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration & Governance
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • SystmOne: NHS Health Checks
        • SystmOne: WorkWell Local Enhanced Service
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • SystmOne: Antibiotics Prescribing & Optimisation
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • SystmOne: Suspected Cancer Referral
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes
          • SystmOne: Diabetes Technology
          • SystmOne Diabetic Kidney Disease
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • SystmOne: Infections
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Ophthalmology
        • Palliative Care and End of Life
        • Chronic Kidney Disease (CKD)
        • Respiratory Resources
        • Rheumatology Overview
          • SystmOne: Osteoporosis and Fragility Fractures
          • Bone Health
      • SystmOne: Weight Management
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination SystmOne
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • SystmOne: Pneumococcal Vaccination
        • RSV Vaccination SystmOne
        • Shingles Vaccination
  • FAQs
  • News
    • Demonstrations
    • Recordings
    • Conference abstracts
  • Contact us
You are here: Home / Resources / EMIS Resource Centre / EMIS Specialties / EMIS: Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS

EMIS: Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS

The CDRC Lipid Management Resource Suite supports GP practices to systematically identify and manage patients who may benefit from lipid screening, initiation of lipid-lowering therapy, treatment optimisation or specialist lipid management.

The suite combines:

  • EMIS Population Reporting searches for identifying relevant patient cohorts.
  • The CDRC Lipid Management Template for assessing and managing individual patients.
  • Clinical decision support for primary prevention, secondary prevention and Familial Hypercholesterolaemia.
  • Support for identifying patients who may meet criteria for PCSK9 inhibitors or Inclisiran.

Together, these resources provide a structured pathway from population-level case finding to individual patient review and clinical action

Reports

Accessing the Reports

CDRC Population Reporting searches are provided directly by the CDRC team. This helps ensure practices receive the appropriate and most current version of the searches, together with any necessary implementation support.

To request access, please email contact-cdrc@healthinnovationnenc.org.uk and a member of the CDRC team will will provide information about access and available support.

This is a temporary arrangement while CDRC develops an enhanced EMIS support service offering improved resource access, regular updates and ongoing support for participating practices.

Report Information:

The CDRC Lipids Reports identify groups of patients who may require:

  • Cardiovascular risk assessment
  • Familial Hypercholesterolaemia screening
  • Clinical review
  • Initiation of lipid-lowering treatment
  • Optimisation of existing treatment
  • Specialist lipid input

The CVD Screening Reports identify patients who may require a formal cardiovascular risk assessment because their estimated cardiovascular risk is 10% or greater.

The FH Case Finding Reports identify patients whose lipid results, diagnoses or recorded information indicate that an assessment for Familial Hypercholesterolaemia may be appropriate.

Report 2.1 Identifies patients with an FH diagnosis code but no associated genetic diagnosis code, supporting record validation and consideration of further assessment under the appropriate pathway

The Consider Medication Initiation Reports identify patients who may benefit from starting lipid-lowering therapy. The reports separate patients according to cardiovascular history and estimated risk allowing for structured prioritisation.

The Consider Medication Optimisation Reports identify patients whose current lipid-lowering therapy may require review or optimisation.

The May Need Specialist Input Reports identify patients who may require more detailed clinical assessment, further treatment intensification or specialist lipid input

The Primary Prevention and Secondary Prevention report folders organise patients into relevant clinical cohorts, allowing practices to take a targeted approach to lipid management.

Primary prevention – Use these reports to identify and manage patients who do not have established cardiovascular disease but may benefit from cardiovascular risk reduction.

Secondary prevention – Use these reports to identify and manage patients with established cardiovascular disease who may benefit from treatment initiation, optimisation or more detailed lipid review.

CDRC Lipid Management Template

The CDRC Lipid Management Template is an intelligent clinical template designed to support individual patient assessment and management.

The template presents relevant information according to:

  • Whether the patient is being assessed for primary or secondary prevention
  • Current lipid-lowering treatment
  • Recorded lipid results
  • Whether a treatment target has been recorded
  • Whether the recorded target has been achieved
  • Treatment suitability and tolerance
  • Whether FH assessment is required

The template supports consistent assessment, clinical coding, treatment decisions and follow-up.

Accessing the Template

The CDRC Precision Resource Launcher must be enabled at the practice before the Lipid Management Template can be opened.

For further information, visit:

  • Accessing the CDRC Precision Resource Launcher

Once enabled:

  1. Open the identified patient’s EMIS record.
  2. Press F12.
  3. Select CDRC Precision Resource Launcher.
  4. Select OK when the launcher opens.
  5. Select Assessment and Management Templates.
  6. Select Cardiovascular.
  7. Open Lipids Management.

The example shows how the template presents relevant lipid results, treatment targets and optimisation guidance for a test patient receiving treatment for secondary prevention.

Additional pages provide support for:

  • FH screening and assessment
  • Hyperlipidaemia aetiology
  • Statin selection and suitability
  • Ezetimibe
  • Inclisiran
  • PCSK9 inhibitors
  • Recorded adverse reactions
  • Contraindications
  • Treatment intolerance

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
contact-cdrc@healthinnovationnenc.org.uk
This website is operated by Health Innovation North East and North Cumbria. Suite A, 2nd Floor, 1 Citygate, Gallowgate, Newcastle upon Tyne NE1 4WH. Registered in England and Wales, Company Registration Number: 08727658
  • Terms of Reference
  • Privacy policy
  • Terms of use
  • Cookie Policy (UK)
  • Accessibility Statement

Copyright © 2026 Clinical Digital Resource Collaborative

Manage Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}